What the changes say
- Top three customers represented 49% of 2025 revenue, increasing concentration exposure.
- International sales rose to 47% of 2025 sales, increasing foreign-market and currency exposure.
- New risks emphasize supplier disruptions, manufacturing-capacity mismatches, activist shareholders, and the $200 million repurchase authorization.
- Stock-price volatility is now tied to ongoing securities class-action litigation and a stated $63.32–$144.36 trading range.
What changed since the prior 10-K
New
- NewOperational Risks
we may not be able to completely offset all the increases in our operational costs, which could adversely affect our results of operations and financial condition
Third-party manufacturers and service providers may face supply-chain, shipping, quality, capacity, or cost problems that disrupt Integer’s production.
- NewOperational Risks
If we are not able to match our manufacturing capacity with demand for our products, our financial results may suffer
Long production cycles make demand forecasting critical; excess demand can cause missed orders, while weak demand leaves costly unused capacity.
- NewStrategic Risks
In addition, some of our competitors outside of the U.S. may have resources and support from their governments that we do not, such as preferences for local manufacturers, and may not be subject to the same tariffs, trade policies, trade compliance regulations and government investigations as us
Non-U.S. competitors may receive government support or face less burdensome tariffs, trade rules, and investigations than Integer.
- NewMarket, Financial and Indebtedness Risks
We cannot guarantee that we will repurchase our common stock pursuant to our share repurchase program or that our share repurchase program will enhance long-term stockholder value. Share repurchases could also increase the volatility of the price of our common stock and could diminish our cash reserves
The $200 million repurchase program is discretionary, may be restricted by debt covenants, and could reduce cash or increase stock-price volatility.
- NewMarket, Financial and Indebtedness Risks
Activist shareholders could negatively impact our business and cause disruptions
Activist shareholder campaigns could impose legal, advisory, public-relations, and proxy costs and distract management from executing its strategy.
Reworded
- 65% rewrittenOperational Risks
We rely on third-party suppliers for raw materials, key products, subcomponents, and services. Unavailability of, or increased prices for, these materials, products, subcomponents, or services could adversely affect our results of operations and financial condition
Copper was added to the listed materials, gallium trichloride was omitted, and industry bans were added as a supply-risk driver.
Was: We rely on third-party suppliers for raw materials, key products and subcomponents. Unavailability of, or increased prices for, these materials, products or subcomponents could adversely affect our results of operations and financial condition
- 64% rewrittenMarket, Financial and Indebtedness Risks
Our operating results may fluctuate, which may make it difficult to forecast our future performance and may result in volatility in our common stock price and declines in the price of common stock could subject us to litigation
The risk now highlights a $63.32–$144.36 2025–2026 stock-price range and current securities class-action litigation.
Was: Our operating results may fluctuate, which may make it difficult to forecast our future performance and may result in volatility in our common stock price
- 58% rewrittenLegal and Compliance Risks
Our business is indirectly subject to healthcare industry third-party coverage and reimbursement and cost containment measures that could result in reduced sales of our products
The emphasis shifted from healthcare cost containment to obtaining favorable government and private-payor coverage and reimbursement approvals.
Was: Our business is indirectly subject to healthcare industry cost containment measures that could result in reduced sales of our products
- 53% rewrittenMarket, Financial and Indebtedness Risks
The conditional conversion features of the 2028 Convertible Notes and the 2030 Convertible Notes could adversely affect our financial condition and operating results
The risk now covers potential early conversion of the 2030 Convertible Notes and reports the 2028 notes’ latest trigger on June 30, 2025.
Was: The conditional conversion feature of the 2028 Convertible Notes could adversely affect our financial condition and operating results
- 48% rewrittenOperational Risks
We depend heavily on a limited number of customers, and if we lose any of them or they significantly reduce their business with us, we would lose a substantial portion of our revenues
Top-three customer concentration increased from 47% of 2024 revenue to 49% of 2025 revenue; most large customers now have long-term agreements.
Was: We depend heavily on a limited number of customers, and if we lose any of them or they reduce their business with us, we would lose a substantial portion of our revenues
- 44% rewrittenStrategic Risks
If we do not respond to changes in technology, our products may become obsolete or less competitive and we may experience a loss of customers and lower revenues
The discussion now adds the need to anticipate customer needs, demands, and shifts in preferences.
- 36% rewrittenLegal and Compliance Risks
The healthcare industry is highly regulated and subject to various political, economic and regulatory changes that could increase our compliance costs and force us to modify how we develop and price our products
No substantive change; the healthcare regulation risk is presented with essentially the same scope and wording.
- 33% rewrittenMarket, Financial and Indebtedness Risks
A significant portion of our sales and operations is currently generated from customers located outside of the U.S., and are subject to a variety of market and financial risks and costs that could adversely affect our profitability and operating results
International sales increased from 45% of 2024 sales to 47% of 2025 sales, with exchange controls and currency restrictions newly specified.
Was: Our international sales and operations are subject to a variety of market and financial risks and costs that could adversely affect our profitability and operating results
- 32% rewrittenOperational Risks
Interruptions of our manufacturing operations could delay production and adversely affect our operations
- 30% rewrittenStrategic Risks
If we are unable to successfully market our current or future products, our business will be harmed and our revenues and operating results will be adversely affected
- 29% rewrittenMarket, Financial and Indebtedness Risks
Certain provisions in the 2028 Convertible Notes, the indenture governing the 2028 Convertible Notes, the 2030 Convertible Notes and the indenture governing the 2030 Convertible Notes could delay or prevent an otherwise beneficial takeover or takeover attempt of us
Was: Certain provisions in the 2028 Convertible Notes and the indenture governing the 2028 Convertible Notes could delay or prevent an otherwise beneficial takeover or takeover attempt of us
- 28% rewrittenMarket, Financial and Indebtedness Risks
These risks are also present in connection with our entry into new geographic markets
- 25% rewrittenMarket, Financial and Indebtedness Risks
Transactions relating to our 2028 Convertible Notes or the 2030 Convertible Notes may affect the market price of our common stock
Was: Transactions relating to our 2028 Convertible Notes may affect the market price of our common stock
- 24% rewrittenMarket, Financial and Indebtedness Risks
We have significant indebtedness that could adversely affect our operations, financial condition, and cash flows if we fail to meet certain financial covenants required by our debt agreements or if our access to capital markets is interrupted
- 22% rewrittenMarket, Financial and Indebtedness Risks
We may never realize the full value of our intangible assets, which represent a significant portion of our total assets
- 20% rewrittenLegal and Compliance Risks
We may be subject to intellectual property claims, which could be costly and time consuming and could divert our management’s attention from our business operations
All 41 risk factors
Headings as the filing states them, in filing order.
Operational Risks
- 01We depend heavily on a limited number of customers, and if we lose any of them or they significantly reduce their business with us, we would lose a substantial portion of our revenues48% rewritten
- 02We are subject to pricing pressures from customers and contractual pricing constraints, which could harm our operating results and financial condition
- 03We rely on third-party suppliers for raw materials, key products, subcomponents, and services. Unavailability of, or increased prices for, these materials, products, subcomponents, or services could adversely affect our results of operations and financial condition65% rewritten
- 04we may not be able to completely offset all the increases in our operational costs, which could adversely affect our results of operations and financial conditionNew
- 05If we are not able to match our manufacturing capacity with demand for our products, our financial results may sufferNew
- 06Interruptions of our manufacturing operations could delay production and adversely affect our operations32% rewritten
- 07We may not be able to attract, train and retain a sufficient number of qualified associates to maintain and grow our business
- 08Quality problems with our products could result in warranty claims and additional costs, could harm our reputation and could erode our competitive advantage
- 09Our operations are subject to cyber-attacks and other information technology disruptions that could have a material adverse effect on our business, results of operations and financial condition
- 10Global climate change and related emphasis on environmental, social and governance (“ESG”) matters by various stakeholders could negatively affect our business or the price of our common stock
- 11We are dependent upon our senior management team and key technical personnel and the loss of any of them could significantly harm us
- 12Consolidation in the healthcare industry could result in greater competition and reduce our revenues and harm our business and our operating results
Strategic Risks
- 13If we are unable to successfully market our current or future products, our business will be harmed and our revenues and operating results will be adversely affected30% rewritten
- 14We may face intense competition that could harm our business, including competitors, insourcing and the possibility of dual sourcing; and we may be unable to compete successfully against new entrants and established companies with greater resources
- 15In addition, some of our competitors outside of the U.S. may have resources and support from their governments that we do not, such as preferences for local manufacturers, and may not be subject to the same tariffs, trade policies, trade compliance regulations and government investigations as usNew
- 16If we do not respond to changes in technology, our products may become obsolete or less competitive and we may experience a loss of customers and lower revenues44% rewritten
- 17We intend to develop new products and expand into new geographic and product markets, which may not be successful and could harm our operating results
- 18If we are not successful in making acquisitions to expand and develop our business, our operating results may suffer
- 19Successful integration and anticipated benefits of acquisitions cannot be assured and integration matters could divert attention of management away from operations
Market, Financial and Indebtedness Risks
- 20Our operating results may fluctuate, which may make it difficult to forecast our future performance and may result in volatility in our common stock price and declines in the price of common stock could subject us to litigation64% rewritten
- 21We cannot guarantee that we will repurchase our common stock pursuant to our share repurchase program or that our share repurchase program will enhance long-term stockholder value. Share repurchases could also increase the volatility of the price of our common stock and could diminish our cash reservesNew
- 22Activist shareholders could negatively impact our business and cause disruptionsNew
- 23We have significant indebtedness that could adversely affect our operations, financial condition, and cash flows if we fail to meet certain financial covenants required by our debt agreements or if our access to capital markets is interrupted24% rewritten
- 24Economic and credit market uncertainty could interrupt our access to capital markets, borrowings, or financial transactions to hedge certain risks, which could adversely affect our business prospects and financial condition
- 25The conditional conversion features of the 2028 Convertible Notes and the 2030 Convertible Notes could adversely affect our financial condition and operating results53% rewritten
- 26Certain provisions in the 2028 Convertible Notes, the indenture governing the 2028 Convertible Notes, the 2030 Convertible Notes and the indenture governing the 2030 Convertible Notes could delay or prevent an otherwise beneficial takeover or takeover attempt of us29% rewritten
- 27Transactions relating to our 2028 Convertible Notes or the 2030 Convertible Notes may affect the market price of our common stock25% rewritten
- 28We are subject to counterparty risk with respect to the capped call transactions for the 2028 Convertible Notes and the 2030 Convertible Notes
- 29A significant portion of our sales and operations is currently generated from customers located outside of the U.S., and are subject to a variety of market and financial risks and costs that could adversely affect our profitability and operating results33% rewritten
- 30These risks are also present in connection with our entry into new geographic markets28% rewritten
- 31We may never realize the full value of our intangible assets, which represent a significant portion of our total assets22% rewritten
Legal and Compliance Risks
- 32Regulatory issues resulting from product complaints, recalls or regulatory audits could harm our ability to produce and supply products or bring new products to market
- 33If we become subject to product liability claims, our operating results and financial condition could suffer
- 34If we are unable to protect our intellectual property and proprietary rights, our business could be harmed
- 35We may be subject to intellectual property claims, which could be costly and time consuming and could divert our management’s attention from our business operations20% rewritten
- 36A failure to comply with customer-driven policies and standards and third-party certification requirements or standards could adversely affect our business and reputation
- 37Our failure to obtain licenses from third parties for new technologies or the loss of these licenses could impair our ability to design and manufacture new products and reduce our revenues
- 38Our business is subject to environmental regulations that could be costly to comply with
- 39Our international operations expose us to legal and regulatory risks, which could adversely affect our business
- 40The healthcare industry is highly regulated and subject to various political, economic and regulatory changes that could increase our compliance costs and force us to modify how we develop and price our products36% rewritten
- 41Our business is indirectly subject to healthcare industry third-party coverage and reimbursement and cost containment measures that could result in reduced sales of our products58% rewritten
Other Integer Holdings 10-Ks
- FY2024 10-K risk factors36 risks
Concentrated customer base creates significant revenue dependency on top clients. Heavy reliance on debt financing and convertible notes impacts capital structure. International sales and operations expose the business to extensive regulatory and currency risks.
Filed Feb 20, 2025
About this page
The headings are the filing's own. The one-line readings and the overview are automated and can be wrong: read Item 1A of the 10-K for the exact wording.